α-Gal immunization positively impacts Trypanosoma cruzi colonization of heart tissue in a mouse model
Authors:
- Maíra Araújo AzevedoMAMaíra Araújo Azevedo
- Denise Silva NogueiraDNDenise Silva Nogueira
- Marianna de Carvalho ClímacoMCMarianna de Carvalho Clímaco
- Juan Atilio Jimenez ChungaJCJuan Atilio Jimenez Chunga
- Raul Jesus Ynocente La ValleRVRaul Jesus Ynocente La Valle
- Carlos Ramon Nascimento BritoCBCarlos Ramon Nascimento Brito
- Rodrigo Pedro SoaresRSRodrigo Pedro Soares
Open Access
- 27 July 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (7) , e0009613
Abstract
Chagas disease, caused by the parasiteTrypanosoma cruzi, is considered endemic in more than 20 countries but lacks both an approved vaccine and limited treatment for its chronic stage. Chronic infection is most harmful to human health because of long-term parasitic infection of the heart. Here we show that immunization with a virus-like particle vaccine displaying a high density of the immunogenic α-Gal trisaccharide (Qβ-αGal) induced several beneficial effects concerning acute and chronicT.cruziinfection in α1,3-galactosyltransferase knockout mice. Approximately 60% of these animals were protected from initial infection with high parasite loads. Vaccinated animals also produced high anti-αGal IgG antibody titers, improved IFN-γ and IL-12 cytokine production, and controlled parasitemia in the acute phase at 8 days post-infection (dpi) for the Y strain and 22 dpi for the Colombian strain. In the chronic stage of infection (36 and 190 dpi, respectively), all of the vaccinated group survived, showing significantly decreased heart inflammation and clearance of amastigote nests from the heart tissue.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (407926/2018-6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303698/2019-5)
- National Institute of Health (1R01AI116577)
- National Institute of Science and Technology for Vaccines (465293/2014-0)
This publication has 87 references indexed in Scilit:
- Advances and challenges towards a vaccine against Chagas diseaseHuman Vaccines, 2011
- Oral Exposure to Trypanosoma cruzi Elicits a Systemic CD8+T Cell Response and Protection against Heterotopic ChallengeInfection and Immunity, 2011
- Pathogenesis of Chagas' Disease: Parasite Persistence and AutoimmunityClinical Microbiology Reviews, 2011
- Tailored Ligand Acceleration of the Cu-Catalyzed Azide−Alkyne Cycloaddition Reaction: Practical and Mechanistic ImplicationsJournal of the American Chemical Society, 2010
- Cardiac Involvement with Parasitic InfectionsClinical Microbiology Reviews, 2010
- Chagas diseaseThe Lancet, 2010
- A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVIMemórias do Instituto Oswaldo Cruz, 2009
- Perspectives on Trypanosoma cruzi–Induced Heart Disease (Chagas Disease)Progress in Cardiovascular Diseases, 2009
- Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) fromTrypanosoma cruziJournal of Leukocyte Biology, 2007
- Structural variation in the glycoinositolphospholipids of different strains ofTrypanosoma cruziGlycoconjugate Journal, 1996